Skip to main content
. 2020 May;61(5):655–661. doi: 10.2967/jnumed.119.232355

FIGURE 1.

FIGURE 1.

Schematic overview of study design. Bevacizumab-800CW (4.5 mg) was administered intravenously 2–3 d before surgery. Fluorescence-guided imaging was performed at every step during pathologic processing: back-table of fresh surgical specimen, tissue slices, and tissue sections. Results were correlated with histopathology.